Belvedere Trading
CCXI

Belvedere Trading’s ChemoCentryx, Inc. CCXI Stock Holding History

Belvedere Trading’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,427
Closed -$1.44M – 714
2021
Q3 		$1.44M Buy
44,427
+10,316
+30% +$161K 0.04% 37
2021
Q2 		$550K Buy
+34,111
New +$840K 0.04% 101

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Belvedere Trading's CCXI Position: Q4 2021 in Review

Belvedere Trading sold out of ChemoCentryx, Inc. (CCXI) in Q4 2021, closing a stake of 44,427 shares — an estimated $1.44M sold.

Belvedere Trading first reported a position in CCXI in Q2 2021 and held it in 2 quarters. The position peaked at $1.44M in Q3 2021. 190 funds tracked by Wall St. Rank hold CCXI as of Q4 2021.

  • Belvedere Trading reported no remaining ChemoCentryx, Inc. position as of Q4 2021 after selling out during the quarter.
  • Belvedere Trading sold 44,427 ChemoCentryx, Inc. shares in Q4 2021, an estimated $1.44M.
  • Belvedere Trading first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 2 quarters.
  • Belvedere Trading's ChemoCentryx, Inc. position peaked at $1.44M in Q3 2021.
  • 190 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2021.

Based on Belvedere Trading's 13F filing for Q4 2021, filed 25 Jan 2022.